Plasma and saliva miR-21 expression in colorectal cancer patients

[1]  B. Nielsen,et al.  miR-21 Is Linked to Glioma Angiogenesis , 2016, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[2]  Yun Yen,et al.  Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol , 2015, Oncotarget.

[3]  Kui Liu,et al.  miR-21: A gene of dual regulation in breast cancer. , 2016, International journal of oncology.

[4]  W. A. Mardin,et al.  MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma , 2015, PloS one.

[5]  K. Shi,et al.  Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation , 2015, Oncotarget.

[6]  M. Veysey,et al.  Folate status, folate-related genes and serum miR-21 expression: Implications for miR-21 as a biomarker , 2015, BBA clinical.

[7]  Q. Jiang,et al.  The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer. , 2015, International journal of clinical and experimental pathology.

[8]  K. Matsuda,et al.  Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer. , 2015, Oncology reports.

[9]  Jun Zhao,et al.  Emerging role of microRNA-21 in colorectal cancer. , 2015, Cancer biomarkers : section A of Disease markers.

[10]  J. Fuscoe,et al.  Age and sex differences in kidney microRNA expression during the life span of F344 rats , 2015, Biology of Sex Differences.

[11]  Qi-shun Zhu,et al.  MicroRNA-21 (miR-21) Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by Targeting PTEN, RECK and Bcl-2 in Lung Squamous Carcinoma, Gejiu City, China , 2014, PloS one.

[12]  Zebo Huang,et al.  Prognostic Value of miR-21 in Various Cancers: An Updating Meta-Analysis , 2014, PloS one.

[13]  M. Ye,et al.  [Diagnostic values of salivary versus and plasma microRNA-21 for early esophageal cancer]. , 2014, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[14]  Yang Wang,et al.  Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis. , 2014, Gene.

[15]  Jing Cai,et al.  Prognostic Role of microRNA-21 in Colorectal Cancer: a Meta-Analysis , 2013, PloS one.

[16]  Supriyo De,et al.  Age-related changes in microRNA levels in serum , 2013, Aging.

[17]  Y. Toiyama,et al.  Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. , 2013, Journal of the National Cancer Institute.

[18]  Dongfeng Li,et al.  Salivary MicroRNAs as Promising Biomarkers for Detection of Esophageal Cancer , 2013, PloS one.

[19]  M. Daumer,et al.  The Diagnostic and Prognostic Role of microRNA in Colorectal Cancer - a Comprehensive review , 2013, Journal of Cancer.

[20]  C. Croce,et al.  microRNA involvement in human cancer. , 2012, Carcinogenesis.

[21]  Shu-Chun Lin,et al.  Exploiting salivary miR‐31 as a clinical biomarker of oral squamous cell carcinoma , 2012, Head & neck.

[22]  Jessica A. Weber,et al.  The microRNA spectrum in 12 body fluids. , 2010, Clinical chemistry.

[23]  A. Schetter,et al.  Association of Inflammation-Related and microRNA Gene Expression with Cancer-Specific Mortality of Colon Adenocarcinoma , 2009, Clinical Cancer Research.

[24]  J. Jameson,et al.  MicroRNAs are novel biomarkers of colorectal cancer , 2009, The British journal of surgery.

[25]  Jing-Yuan Fang,et al.  MicroRNA regulatory network in human colorectal cancer. , 2009, Mini reviews in medicinal chemistry.

[26]  T. Kirchner,et al.  The impact of microRNAs on colorectal cancer , 2009, Virchows Archiv.

[27]  William E Grizzle,et al.  Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. , 2009, Journal of proteome research.

[28]  C. Florkowski.  Sensitivity, specificity, receiver-operating characteristic (ROC) curves and likelihood ratios: communicating the performance of diagnostic tests. , 2008, The Clinical biochemist. Reviews.

[29]  George A Calin,et al.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. , 2008, JAMA.

[30]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[31]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .